Related Experiment Videos

Shortcomings in pharmacy benefit forecasting--interferon beta products

Sheldon J Rich, Christina Meyer

Journal of Managed Care Pharmacy : JMCP

|November 14, 2003

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Organophosphate Chemical Nerve Agents, Oxidative Stress, and NADPH Oxidase Inhibitors: An Overview.

International journal of molecular sciences·2025

Mitigating organophosphate nerve agent, soman (GD), induced long-term neurotoxicity: Saracatinib, a Src Tyrosine Kinase inhibitor, as a potential countermeasure.

Journal of neuroinflammation·2025

Mitigating Organophosphate Nerve Agent, Soman (GD)-Induced Long-Term Neurotoxicity: Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Potential Countermeasure.

Research square·2025

Off-target effects of the NADPH oxidase inhibitor mitoapocynin-encapsulated nanoparticles and free-drug oral treatment in a rat DFP model of neurotoxicity.

Journal of drug targeting·2025

Diet-incorporated saracatinib, a Src tyrosine kinase inhibitor, counteracts diisopropylfluorophosphate (DFP)-induced chronic neurotoxicity in the rat model.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

An economic evaluation of breast cancer interventions in Kenya.

EClinicalMedicine·2024

See all related articles